Genomics

Dataset Information

0

Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T cell lymphoma [ChIP-seq]


ABSTRACT: Peripheral T cell lymphoma (PTCL) is a heterogeneous group of hematological cancers arising from the malignant transformation of mature T cells. In a cohort of 28 PTCL cases, we identified recurrent overexpression of MYCN, a member of the MYC family of oncogenic transcription factors. Approximately half of all PTCL cases was characterized by a MYC expression signature. Inducible expression of MYCN in lymphoid cells in a mouse model caused T cell lymphoma that recapitulated human PTCL with a MYC expression signature. Integration of mouse and human expression data identified EZH2 as a key downstream target of MYCN. Remarkably, EZH2 was found to be an essential co-factor for the transcriptional activation of the MYCN-driven gene expression program, which was independent of methyltransferase activity, but dependent on phosphorylation by CDK1. MYCN-driven T cell lymphoma was sensitive to EZH2 degradation or CDK1 inhibition, which displayed synergy with FDA-approved HDAC inhibitors.

ORGANISM(S): Mus musculus

PROVIDER: GSE198125 | GEO | 2022/09/01

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2022-09-01 | GSE198124 | GEO
2022-02-17 | PXD029652 | Pride
2015-06-01 | GSE58445 | GEO
2015-02-01 | E-GEOD-64537 | biostudies-arrayexpress
2019-09-19 | GSE132550 | GEO
2021-11-27 | GSE160119 | GEO
2015-02-01 | GSE64537 | GEO
2012-07-31 | E-GEOD-36172 | biostudies-arrayexpress
2021-08-26 | GSE182769 | GEO
2018-11-09 | GSE122347 | GEO